Patients Stopping Slimming Jabs Put On Weight at a Quadrupled Rate Than People Using Diet and Exercise

New research reveals that patients who come off blockbuster weight-loss injections like Mounjaro or Wegovy may regain shed pounds far faster than those who end conventional lifestyle regimens.

Research printed in a major health publication demonstrates that while obese people often shed a large proportion of their total mass while on the medication, the mass is regained at an estimated rate of nearly a kilo each month once they quit.

"Individuals buying these treatments must be informed of the risk of quick weight regain when the medication concludes," cautioned researcher Dr. Susan Jebb.

This pace of recovery means a reversion to original mass within about a year and a half.

Comparing Approaches

The study, which examined 37 of studies involving over 9,000 of participants, compared the results of the injectable medications with older methods.

Scientists emphasize that people who shed pounds through lifestyle changes alone usually experience a less rapid creep back—around 100 grams monthly—post-intervention.

Understanding the Rapid Rebound

Doctors believe the way of the drugs accounts for the heightened rebound.

The injections mimic a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Sustained high doses of the hormone concentrations several times higher than normal could lead to the system to generate a reduced amount of its own natural GLP-1, and may also lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.

"Withdrawal of this GLP-1 'fix' means appetite is no longer kept in check, making binge eating much more probable."

A Chronic Condition?

The NHS suggest the injections for individuals with obesity-related health risks, alongside recommended lifestyle changes.

Many experts argue that, given the likelihood of relapse, the treatment is often life-long.

This opinion is supported by pharmaceutical companies, who state that the findings "underscore the long-term nature of obesity," akin to managing conditions like hypertension.

Patient Accounts

Users who have discontinued the medication explain a intense return of hunger.

"I experienced a switch flipping and you become extremely hungry," recalled a patient.

The struggle is compounded if individuals have not established lasting dietary or behavioural changes during therapy.

Growing Interest

Figures suggest that millions of adults in the UK have used these injections in the last 12 months, with interest being substantial.

• Use is greater among females compared to males.
• The middle-aged demographic shows the greatest usage rates.
• Many access the drugs through private healthcare rather than the NHS.

In conclusion, clinicians emphasize that while these medications are potent tools for weight loss, they are not a magic cure and long-term success relies on integrated behavioural support.